Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.
Yamazaki
Rie
R
Okamoto
Shinichiro
S
Chen
Chien-Kang
CK
Tada
Shinichiro
S
Saito
Hidetane
H
Shibata
Rie
R
Sakamoto
Michiie
M
Mori
Takehiko
T
Ikeda
Yasuo
Y
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001549:Benzamides; D001706:Biopsy; D001752:Blast Crisis; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008099:Liver / Q000293:injuries* / Q000473:pathology; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate